| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An overview of the Fourth International Symposium on Hodgkin’s Disease
|
Parsa-Parsi, R.
|
|
|
9 |
S5 |
p. s1-s3
|
artikel
|
| 2 |
BEACOPP: A new regimen for advanced Hodgkin’s disease
|
Diehl, V.
|
|
|
9 |
S5 |
p. s67-s71
|
artikel
|
| 3 |
Clonality and germinal centre B-cell derivation of Hodgkin/Reed–Sternberg cells in Hodgkin’s disease
|
Küppers, R.
|
|
|
9 |
S5 |
p. s17-s20
|
artikel
|
| 4 |
Copyright
|
|
|
|
9 |
S5 |
p. v
|
artikel
|
| 5 |
Current clinical trials for the treatment of adult Hodgkin’s disease: Common strategies and perspectives
|
Wolf, J.
|
|
|
9 |
S5 |
p. s79-s82
|
artikel
|
| 6 |
Editorial board
|
|
|
|
9 |
S5 |
p. vi
|
artikel
|
| 7 |
Epstein–Barr virus in Hodgkin’s disease
|
Chapman, A.L.N.
|
|
|
9 |
S5 |
p. s5-s16
|
artikel
|
| 8 |
Hodgkin’s disease: Quality of life in future trials
|
Kaasa, S.
|
|
|
9 |
S5 |
p. s137-s145
|
artikel
|
| 9 |
Immune escape mechanisms in Hodgkin’s disease
|
Poppema, S.
|
|
|
9 |
S5 |
p. s21-s24
|
artikel
|
| 10 |
Long-term toxicity of the treatment of Hodgkin’s disease
|
Armitage, J.O.
|
|
|
9 |
S5 |
p. s133-s136
|
artikel
|
| 11 |
Lymphocyte predominant Hodgkin’s disease: Pathology and clinical implication* * Participants are listed in the Acknowledgements.
|
Franklin, J.
|
|
|
9 |
S5 |
p. s39-s44
|
artikel
|
| 12 |
Model based development of the BEACOPP regimen for advanced stage Hodgkin’s disease
|
Loeffler, M.
|
|
|
9 |
S5 |
p. s73-s78
|
artikel
|
| 13 |
Molecular basis of targeted chemotherapy: Novel concepts with special reference to the treatment of Hodgkin’s disease
|
Grunicke, H.H.
|
|
|
9 |
S5 |
p. s125-s128
|
artikel
|
| 14 |
New drugs in the treatment of Hodgkin’s disease
|
Borchmann, P.
|
|
|
9 |
S5 |
p. s103-s108
|
artikel
|
| 15 |
Pediatric Hodgkin’s disease: Treatment in the late 1990s
|
Schellong, G.
|
|
|
9 |
S5 |
p. s115-s119
|
artikel
|
| 16 |
Primary refractory Hodgkin’s disease
|
Horning, S.J.
|
|
|
9 |
S5 |
p. s97-s101
|
artikel
|
| 17 |
Quality of life assessment in Hodgkin’s disease: A new comprehensive approach
|
Flechtner, H.
|
|
|
9 |
S5 |
p. s147-s154
|
artikel
|
| 18 |
Radiation therapy as a component of high-dose salvage strategies in Hodgkin’s disease
|
Hoppe, R.T.
|
|
|
9 |
S5 |
p. s87-s90
|
artikel
|
| 19 |
Radiotherapy in early stage Hodgkin’s disease: Principles and results of recent clinical trials
|
Noordijk, E.M.
|
|
|
9 |
S5 |
p. s63-s65
|
artikel
|
| 20 |
Rare syndromes in Hodgkin’s disease
|
Cavalli, F.
|
|
|
9 |
S5 |
p. s109-s113
|
artikel
|
| 21 |
Table of Contents
|
|
|
|
9 |
S5 |
p. iv-v
|
artikel
|
| 22 |
The case for and against high-dose therapy with stem cell rescue for early poor prognosis Hodgkin’s disease in first remission
|
Goldstone, A.H.
|
|
|
9 |
S5 |
p. s83-s85
|
artikel
|
| 23 |
The many faces of Hodgkin’s disease around the world: What have we learned from its pathology?
|
Harris, N.L.
|
|
|
9 |
S5 |
p. s45-s56
|
artikel
|
| 24 |
The role of radiotherapy for early stage Hodgkin’s disease: Limitations and perspectives
|
Cosset, J.-M.
|
|
|
9 |
S5 |
p. s57-s62
|
artikel
|
| 25 |
Title Page
|
|
|
|
9 |
S5 |
p. iii
|
artikel
|
| 26 |
Treatment of grey zone lymphomas
|
Fisher, R.I.
|
|
|
9 |
S5 |
p. s121-s123
|
artikel
|
| 27 |
Treatment of relapsed Hodgkin’s disease: Strategies and prognostic factors
|
Canellos, G.P.
|
|
|
9 |
S5 |
p. s91-s96
|
artikel
|
| 28 |
Treatment of relapsed Hodgkin’s disease using EBV-specific cytotoxic T cells
|
Rooney, C.M.
|
|
|
9 |
S5 |
p. s129-s132
|
artikel
|
| 29 |
Workshop report on Hodgkin’s disease and related diseases (‘grey zone’ lymphoma)
|
Rüdiger, T.
|
|
|
9 |
S5 |
p. s31-s38
|
artikel
|
| 30 |
World Health Organization Classification of lymphomas: A work in progress
|
Jaffe, E.S.
|
|
|
9 |
S5 |
p. s25-s30
|
artikel
|
Tijdschrift beschrijving